We did not find any significant differences in CD14+ cells in cancer patients compared to HD (Kruskal-Wallis test; p = 0.222, CRC: 2.4 ± 0.5; PBC: 2.3 ± 0.4; and HD: 3.4 ± 0.6; Figure 1(d)). Here, CD14 is linked to cancer.